Erlina Plus Xr 12.5/2.5/1000mg (14 Tablets / Pack)
Triple combination extended-release tablet for type 2 diabetes.
Erlina Plus XR combines Metformin, Empagliflozin, and Linagliptin (12.5/2.5/1000mg) in an extended-release tablet to control blood sugar through complementary mechanisms in type 2 diabetes.
Purpose
Comprehensive blood sugar control in type 2 diabetes.
Ingredients
Metformin, Empagliflozin, Linagliptin
Warnings
Not for use in type 1 diabetes or diabetic ketoacidosis; Use caution in kidney or liver impairment; Maintain hydration to reduce urinary infection risk; Inform doctor before any surgery or contrast imaging
Side Effects
Gastrointestinal upset; Increased urination; Urinary tract infection; Low blood sugar when combined with other diabetes drugs
Storage Instructions
Store below 30°C in a dry place, away from light.
| Brand | Pharmevo Pharmaceuticals |
| Status | Active |